Log inLog out
Report
This is a proof-of-concept page demonstrating how large language models can build and maintain a research database. It has not been audited by a human, may contain errors, and must not be relied upon for accuracy. Use at your own risk — this is not investment advice and must not be used for investment purposes.

IDEX Corporation

From ReportWarehouse, the free investment-report repository

IDEX Corporation is an American diversified industrial technology company that designs, manufactures, and distributes precision fluidics, pumps, sealing solutions, optical components, fire-safety equipment, and engineered banding systems across over 50 wholly-owned subsidiaries, generating $3.46 billion in net sales in fiscal 2025. The company operates through three segments — Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP) — serving niche markets where its components are critical to system performance but represent a small fraction of the customer's total cost, a formula that has historically produced high returns on capital and substantial free cash flow.

This is a story about a portfolio of niche industrial franchises that has spent the last five years repositioning toward faster-growing, technology-intensive end markets — semiconductor fabrication, data-center infrastructure, space and defense, life sciences — while sustaining best-in-class margins in its legacy fluidics and fire-safety businesses. The repositioning is not hypothetical. In the second quarter of 2026, HST posted 47% organic order growth and 12% organic revenue growth, driven by demand from AI-related power generation, semiconductor capital equipment, and satellite communications, while FMT's municipal water and mining platforms also delivered double-digit order increases.

The file turns on a single question: whether the growth acceleration in HST is durable enough to offset what remains a sluggish industrial cycle in FMT, and whether the market's current valuation — roughly 33 times trailing earnings and approximately 19.2 times trailing EBITDA — already discounts several years of that compounding. The answer depends less on IDEX's execution, which has been strong, than on the staying power of the AI capex cycle and the timing of a broad industrial recovery that has teased but not yet arrived.

Full report locked

You are viewing the public summary. The full report — business breakdown, key debates, financials, scenarios, charts and risks — is available to password holders.

Log in to read the full report →

Invitation-only proof of concept. Not investment advice.

Categories: IndustrialsDiversified industrial technologyFluidics and precision componentsNYSE-listed companiesSerial acquirer80/20 operating model